Target intelligence / Profile preview

Cellular pathways modulated via exosomal cargo

Molecular classification
Extracellular vesicles, Intercellular signaling mechanism
01

Overview

Cellular pathways modulated via exosomal cargo represent a sophisticated mode of intercellular communication where exosomes—small extracellular vesicles (30–150 nm)—transfer bioactive molecules to recipient cells. These vesicles carry a diverse array of cargo, including microRNAs (miRNAs), messenger RNAs (mRNAs), proteins, and lipids, which are protected from extracellular degradation by a lipid bilayer [PMID: 23443682]. Upon internalization via endocytosis or direct membrane fusion, the exosomal cargo can trigger or inhibit specific intracellular signaling cascades such as the PI3K/Akt, Wnt/β-catenin, and MAPK pathways [PMID: 30111560]. In the context of oncology, tumor-derived exosomes are known to modulate pathways that promote epithelial-mesenchymal transition (EMT), angiogenesis, and the formation of the pre-metastatic niche [PMID: 26040764]. Furthermore, exosomal cargo can mediate immune evasion by delivering inhibitory signals to T-cells or polarizing macrophages toward a pro-tumorigenic phenotype [PMID: 28533410]. Therapeutically, this mechanism is being exploited for the development of bioengineered exosomes as targeted drug delivery systems, while inhibitors of exosome biogenesis, such as GW4869, are being researched to halt the progression of exosome-mediated pathologies [PMID: 29346733].

Other names
Exosome-mediated signalingExtracellular vesicle-mediated communicationExosomal cargo deliveryEV-mediated pathway modulation
02

Mechanism of action

Horizontal transfer of bioactive molecules (miRNAs, proteins, lipids) that modulate signaling pathways and gene expression in recipient cells [PMID: 23443682].

03

Biological functions

Intercellular communicationSignal transductionEpigenetic regulationImmune modulationProtein and RNA transport
04

Disease associations

CancerNeurodegenerative diseaseInflammationCardiovascular diseaseViral infection
05

Safety considerations

Off-target effectsPotential immunogenicityHeterogeneity of exosome populationsRisk of unintended disease propagation
06

Interacting drugs

GW4869

3 more in the full profile.

07

Biomarkers

CD63CD81CD9TSG101AlixExosomal miR-21

Beyond the preview

Go deeper on Cellular pathways modulated via exosomal cargo.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular pathways modulated via exosomal cargo.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call